Supplement
N-Acetyl Glucosamine
SaveAn acetylated form of glucosamine that is a building block of hyaluronic acid and glycosaminoglycans. Studied for joint health, gut barrier function, and inflammatory bowel disease.
Quick verdict
Modest evidence for joint and gut health, with some interesting IBD data. May offer distinct benefits from standard glucosamine through different metabolic pathways.
Evidence score
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
N-acetyl glucosamine (NAG) is a precursor to hyaluronic acid and glycosaminoglycans in the gut lining. Small studies in children with IBD showed mucosal healing. It enters the hexosamine biosynthetic pathway differently from glucosamine sulfate. Joint health evidence is more limited than standard glucosamine.
Benefits
- Building block for hyaluronic acid and gut glycosaminoglycans
- May support gut mucosal barrier integrity
- Preliminary evidence for inflammatory bowel disease
Dosage notes
Typical doses: 500-1500 mg daily. IBD studies used higher doses under medical supervision. Often combined with other joint support compounds.
Side effects
- Generally well-tolerated
- Mild GI discomfort
- Shellfish allergy concern for some products
Who should be cautious
Derived from shellfish in most forms. May affect blood glucose via hexosamine pathway signaling.
What this page cannot tell you
IBD studies are small and uncontrolled. Joint health evidence is more limited than for glucosamine sulfate. The two forms are not interchangeable.
Leaderboard scores
- Pain32
- Recovery28
- Immunity25
Write a review
Sign in to write a review.